Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Introduction
00:00 • 3min
Nateen Jain on Chronic Lymphoma and Leukemia
03:17 • 3min
The Leukemia Fellowship Program at HEMON
05:57 • 2min
The Leukemia Fellowship at M.D. Anderson
07:45 • 2min
The Importance of CLL Treatment
09:54 • 4min
CLL Fish Panel: What Is the Minimum Prognostic Mark?
14:01 • 3min
The Importance of Chemotherapy for Mutated iGvH
16:47 • 4min
Ibrutinib and Zenu for CLL
20:44 • 2min
Ibrutinib Akhala and Zenu: Which Is Better?
22:43 • 2min
Ibrutinib vs. Akhala Obin: A Comparison
24:30 • 2min
Xano Brootene: A Superior Drug to the Brootene
26:53 • 2min
The Advantages of Vinito Clacks Over BTK Inhibitors
29:13 • 4min
Why Karambezel Remains a Comparator Arm for CLL
32:49 • 3min
The Role of Retuxin in CLL Treatment
35:34 • 3min
How to Define MRD Negative
38:35 • 5min
How to Stop Vinitor Clacks for Patients With 17p Deletion
43:24 • 2min
How to Check MRD for CLL Established Cross
45:21 • 2min
How to Treat Relapse Disease
47:02 • 3min
The Benefits of Vneetoclax
49:53 • 4min
Allergenic Cars for CLL Patients
54:00 • 4min
The Future of Chronic Lymphoma
57:31 • 3min